LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR)

CUSIP: 514766104

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock
Shares outstanding
37,508,353
Total 13F shares
23,496,502
Share change
-447,347
Total reported value
$272,006,071
Put/Call ratio
0%
Price per share
$11.58
Number of holders
94
Value change
-$4,453,715
Number of buys
43
Number of sells
44

Security key

514766104

Report period

Q1 2022

Institutions

94

Top holders

10

Top shareholders of LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
WYNNEFIELD CAPITAL INC
13F
Company
8.4%
3,145,887
$34,919,000 31 Dec 2021
13F
Legion Partners Asset Management, LLC
13F
Company
7.8%
2,928,090
$32,502,000 31 Dec 2021
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
5.3%
1,973,608
$21,907,000 31 Dec 2021
13F
BlackRock Finance, Inc.
13F
Company
5.2%
1,946,458
$21,605,000 31 Dec 2021
13F
ISZO CAPITAL MANAGEMENT LP
13F
Company
5.1%
1,925,311
$21,371,000 31 Dec 2021
13F
Cove Street Capital, LLC
13F
Company
4.8%
1,796,364
$19,940,000 31 Dec 2021
13F
VANGUARD GROUP INC
13F
Company
3.4%
1,257,836
$13,961,000 31 Dec 2021
13F
HEARTLAND ADVISORS INC
13F
Company
3.3%
1,224,615
$13,593,000 31 Dec 2021
13F
22NW, LP
13F
Company
3.3%
1,223,175
$13,577,000 31 Dec 2021
13F
KENNEDY CAPITAL MANAGEMENT LLC
13F
Company
1.9%
704,722
$7,822,000 31 Dec 2021
13F
MORGAN STANLEY
13F
Company
1.6%
601,744
$6,680,000 31 Dec 2021
13F
Pacific Ridge Capital Partners, LLC
13F
Company
1.4%
539,454
$5,988,000 31 Dec 2021
13F
Visionary Wealth Advisors
13F
Company
1.3%
498,670
$5,535,000 31 Dec 2021
13F
STATE STREET CORP
13F
Company
1.2%
468,143
$5,196,000 31 Dec 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.2%
461,081
$5,117,000 31 Dec 2021
13F
Assenagon Asset Management S.A.
13F
Company
1.2%
454,990
$5,050,000 31 Dec 2021
13F
TOCQUEVILLE ASSET MANAGEMENT L.P.
13F
Company
1.1%
421,950
$4,684,000 31 Dec 2021
13F
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
13F
Company
1.1%
401,638
$4,458,000 31 Dec 2021
13F
Russell Investments Group, Ltd.
13F
Company
0.78%
293,588
$3,256,000 31 Dec 2021
13F
IQ EQ FUND MANAGEMENT (IRELAND) Ltd
13F
Company
0.68%
255,126
$2,832,000 31 Dec 2021
13F
FULLER & THALER ASSET MANAGEMENT, INC.
13F
Company
0.68%
254,195
$2,822,000 31 Dec 2021
13F
NORTHERN TRUST CORP
13F
Company
0.65%
244,369
$2,713,000 31 Dec 2021
13F
Point72 Asset Management, L.P.
13F
Company
0.47%
177,019
$1,965,000 31 Dec 2021
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.46%
170,874
$1,897,000 31 Dec 2021
13F
Defender Capital, LLC.
13F
Company
0.34%
126,450
$1,404,000 31 Dec 2021
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.31%
116,700
$1,295,000 31 Dec 2021
13F
Nuveen Asset Management, LLC
13F
Company
0.3%
114,186
$1,222,000 31 Dec 2021
13F
Bank of New York Mellon Corp
13F
Company
0.3%
113,014
$1,255,000 31 Dec 2021
13F
Boston Partners
13F
Company
0.29%
107,693
$1,195,000 31 Dec 2021
13F
ROYAL BANK OF CANADA
13F
Company
0.29%
107,322
$1,191,000 31 Dec 2021
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.28%
105,000
$1,166,000 31 Dec 2021
13F
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.
13F
Company
0.27%
99,442
$1,104,000 31 Dec 2021
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.26%
97,775
$1,085,000 31 Dec 2021
13F
Employees Retirement System of Texas
13F
Company
0.23%
85,400
$948,000 31 Dec 2021
13F
ROYCE & ASSOCIATES LP
13F
Company
0.2%
75,610
$839,000 31 Dec 2021
13F
GAMCO INVESTORS, INC. ET AL
13F
Company
0.19%
73,000
$810,000 31 Dec 2021
13F
Ancora Advisors LLC
13F
Company
0.19%
70,549
$783,000 31 Dec 2021
13F
Allspring Global Investments Holdings, LLC
13F
Company
0.19%
70,383
$781,000 31 Dec 2021
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.18%
66,364
$737,000 31 Dec 2021
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.16%
60,983
$677,000 31 Dec 2021
13F
Invesco Ltd.
13F
Company
0.15%
57,267
$636,000 31 Dec 2021
13F
D. E. Shaw & Co., Inc.
13F
Company
0.15%
54,591
$606,000 31 Dec 2021
13F
OPPENHEIMER ASSET MANAGEMENT INC.
13F
Company
0.15%
54,479
$605,000 31 Dec 2021
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.14%
53,990
$600,000 31 Dec 2021
13F
UBS Group AG
13F
Company
0.13%
47,211
$524,000 31 Dec 2021
13F
RHUMBLINE ADVISERS
13F
Company
0.11%
39,530
$439,000 31 Dec 2021
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.09%
33,413
$371,000 31 Dec 2021
13F
BARCLAYS PLC
13F
Company
0.09%
32,731
$363,000 31 Dec 2021
13F
Riverwater Partners LLC
13F
Company
0.09%
32,667
$363,000 31 Dec 2021
13F
JPMORGAN CHASE & CO
13F
Company
0.08%
31,039
$344,000 31 Dec 2021
13F

Institutional Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q1 2022

As of 31 Mar 2022, LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) was held by 94 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,496,502 shares. The largest 10 holders included WYNNEFIELD CAPITAL INC, Legion Partners Asset Management, LLC, DIMENSIONAL FUND ADVISORS LP, BlackRock Inc., Cove Street Capital, LLC, VANGUARD GROUP INC, 22NW, LP, HEARTLAND ADVISORS INC, MORGAN STANLEY, and Pacific Ridge Capital Partners, LLC. This page lists 94 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 holders
95
Q1 2022 holders
94
Holder diff
-1
Investor Q4 2021 Shares Q1 2022 Shares Share Diff Share Chg % Q4 2021 Value $ Q1 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .